Pharming Group (OTCMKTS:PHGUF – Get Free Report) crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.81 and traded as high as $0.99. Pharming Group shares last traded at $0.98, with a volume of 3,000 shares trading hands.
Pharming Group Trading Up 2.3 %
The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.76 and a current ratio of 3.53. The company has a market cap of $640.67 million, a P/E ratio of -49.10 and a beta of 1.11. The business has a fifty day simple moving average of $0.81 and a 200 day simple moving average of $0.81.
About Pharming Group
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.
Recommended Stories
- Five stocks we like better than Pharming Group
- Top Biotech Stocks: Exploring Innovation Opportunities
- Top 3 Investment Themes to Watch for in 2025
- Find and Profitably Trade Stocks at 52-Week Lows
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.